CARA: Cara Therapeutics Company Short-Term Debt
Cara Therapeutics, Inc. (CARA) attracts scientists through the development of specific pain management treatments, maintaining a rigorous scientific approach and a stock option system. The business relies on the creation of unique antipruritic drugs, which provides the pricing power to set premium product costs within a narrow niche. This daily price chart reflects the dynamics of short-term liabilities, which currently stand at 0.00. Environmental policy is limited to laboratory safety and digital documentation.
Analytical breakdowns for Cara Therapeutics Inc (CARA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Cara Therapeutics, Inc.|CARA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Cara Therapeutics, Inc.|CARA - Company Aggregate Debts|Debt to Book Value Cara Therapeutics, Inc.|CARA - Company Long-Term Loans and Borrowings|Company Current Liabilities Cara Therapeutics|Quick Ratio caratherapeutics.com
- net income and valuation multiples indicators:
Analysis of all company metrics:Cara Therapeutics - CARA
Investors must weigh the potential for share price growth against the debt load to avoid purchasing an overleveraged asset. The dynamics of the organization's short-term debt reflect the daily pace of loan refinancing and interest rate sensitivity, which is critical for Cara Therapeutics, Inc. (CARA) as it awaits royalties from Korsuva and finances trials for the drug's oral formulation.
Competing companies
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Current Liabilities xenon-pharma.com (XENE)|Company Short-Term Debts VKTX|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Company Short-Term Loans and Borrowings DNLI|Harmony Biosciences - Company Short-Term Debts|BHVN - Company Short-Term Debts|AMLX (Amylyx Pharmaceuticals, Inc.) - Company Current Liabilities|Trevi Therapeutics Inc - Company Short-Term Loans and Borrowings|Company Current Liabilities PRAX|AVXL (Anavex Life Sciences Corp) - Amount of Current Liabilities|Company Short-Term Debts CBLL|PRTA (Prothena Corporation plc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ALEC (Alector)|Annexon Biosciences (ANNX) - Short-Term Debt|OMER - Company Short-Term Debt|Company Short-Term Loans and Borrowings NGNE (Neurogene Therapeutics)|ACIU: Company Short-Term Debts|voyagertherapeutics.com (VYGR) - Company Short-Term Debts|Company Short-Term Debt Neumora Therapeutics, Inc.|Scilex Holding - Current Liabilities|Company Short-Term Debts TVGN|ACOG - Short-Term Debt|Cognition Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts inhibikase.com IKT|SAVA: Company Current Liabilities|Assertio Holdings, Inc. - Amount of Current Liabilities|COYA: Company Short-Term Debts|VTGN - Short-Term Debt Volume|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Company Current Liabilities acumenpharm.com (ABOS)|Company Short-Term Debt CervoMed (CRVO)|Short-Term Debt Volume alteritytherapeutics.com|Clene - Company Current Liabilities|Company Short-Term Loans and Borrowings PEPG|Jupiter Neurosciences - Company Short-Term Debts|Short-Term Debt Volume relmada.com RLMD|Annovis Bio (ANVS) - Company Short-Term Debt|Company Short-Term Indebtedness GRCE|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|Company Current Liabilities ANEW Medical, Inc. (KLTO)|Company Current Liabilities NRSN (NeuroSense Therapeutics)|Short-Term Debt Volume revivapharma.com|Company Short-Term Debts MTVA (MetaVia)|NRXS - Company Current Liabilities|Helius Medical Technologies Inc. - Company Short-Term Debts|PASG - Company Short-Term Debts|bionomics.com.au (NEUP) - Company Short-Term Debt|minervaneurosciences.com - Company Short-Term Loans and Borrowings|ATHA (Athira Pharma) - Company Short-Term Debts|Company Short-Term Debts Addex Therapeutics Ltd.|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|cyclerion.com - Company Short-Term Indebtedness|Company Short-Term Debts PTIX (Protagenic Therapeutics, Inc.)|Pasithea Therapeutics Corp (KTTA) - Short-Term Debt|CRGT: Company Current Liabilities|ATXI - Company Short-Term Debts|Brainstorm Cell Therapeutics, Inc. (BCLI) - Company Short-Term Debt|Chromocell - Company Short-Term Loans and Borrowings|Company Short-Term Debt Eliem Therapeutics, Inc.|Short-Term Debt Intra-Cellular ITCI|Company Short-Term Debts LBPH|Company Current Liabilities Marinus Pharmaceuticals Inc MRNS|Company Short-Term Debts NKGN (NKGen)|Company Short-Term Debts NeuroBo Pharma NRBO|SAGE - Company Short-Term Debt|Company Short-Term Loans and Borrowings SNPX (synaptogen.com)|TRVN: Company Short-Term Debts|Vigil Neuroscience, Inc. (VIGL) - Company Short-Term Debts|Company Current Liabilities WENA|CERE: Company Short-Term Loans and Borrowings